Clinical Trial Update: Aripiprazole Oral Acceptability Trial [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the oral acceptability of aripiprazole in schizophrenia has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• ARIPIPRAZOLE (Aripiprazole)

Snippet

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED